Overview

A Clinical Study of Safety and P2Y12 Receptor Inhibition Effects of Ticagrelor and Clopidogrel in Vietnamese Patient

Status:
Withdrawn
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
Study in Vietnamese Patients with Coronary Heart Disease to investigate safety and P2Y12 Receptor Inhibition Effects of Ticagrelor and Clopidogrel
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Clopidogrel
Ticagrelor
Ticlopidine